Eden Research plc
EDNSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.06 | -0.45 | -0.20 | 0.09 |
| FCF Yield | -3.87% | 1.42% | -5.95% | -3.97% |
| EV / EBITDA | -7.76 | -22.77 | -14.76 | -20.80 |
| Quality | ||||
| ROIC | -16.22% | -8.15% | -7.22% | -5.56% |
| Gross Margin | 12.96% | 52.90% | 31.49% | 65.06% |
| Cash Conversion Ratio | 0.39 | -0.30 | 1.43 | 1.11 |
| Growth | ||||
| Revenue 3-Year CAGR | 27.75% | 29.93% | 6.27% | 1.34% |
| Free Cash Flow Growth | -276.33% | 122.00% | -74.39% | 46.30% |
| Safety | ||||
| Net Debt / EBITDA | 0.80 | 4.56 | 3.93 | 12.06 |
| Interest Coverage | -205.30 | 0.00 | -219.86 | -86.66 |
| Efficiency | ||||
| Inventory Turnover | 2.28 | 2.14 | 2.09 | 0.74 |
| Cash Conversion Cycle | 37.13 | -53.67 | 0.07 | -30.18 |